Business Wire

IMPROBABLE

Share
Improbable ventures into new worlds, unveils robust financial performance, underpinned by exciting innovation developments and standout progress made through recent sports events

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230926212157/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Graphic: Business Wire)

Highlights

  • With a combination of gaming technology, new AI capabilities and metaverse infrastructure, the metaverse is delivering more interesting, exciting and useful experiences, boosted by the creator economy. For instance, sports has taken the lead in investments and ambitious projects, driven by the appetite of current and new fans for exclusive, fun content that enables them to consume their sport in a unique fashion with their community, and allowing rights owners new and innovative ways to monetize their content.
  • Having completed its transformation, Improbable is now clarifying its brand mission as a venture builder, creating new ventures based upon its own backbone technology. The company has reorganized and now has three primary areas of activities:
    • Metaverse technology development
    • Metaverse and metaversal experiences development
    • Metaverse venture building, supported by an experimentation arm, Improbable Labs.
  • The new operating model is lean and comes to improve the company’s capabilities to deliver content at scale. With already 22 events run over the past 6 months, the company’s goal is to deliver close to 300 such events next year.
  • The technology roadmap focuses on enabling a regular cadence for events, supported by easy to use and affordable content creation tool sets and self-serve functionalities all embedded within the M2 network. A new product will be announced shortly, including advances in rendering that allow for the coupling of Improbable mass-scale technology with generative AI.
  • 2022 financial performance is very solid and meets guidance with a 2.6x improvement at £78m in revenue and £131m in profit improvement.

Innovation Day - Further Details

Held on 26 September 2023, Improbable’s Innovation Day provided for a strategic update on the company and its business and financial performance for 2022. The leadership team highlighted the momentum across the business, including a significant improvement in revenue growth and net profit performance.

Herman Narula, Chief Executive Officer of Improbable, says, “Today showcases how far we have come and validates our metaverse focus, yet there is still so much to go after for this business. Opportunities abound in sports, entertainment and music. Our proprietary technology is able to take fan engagement and experiences to a new level and we gather ever more users excited by new experiences happening in the metaverse. Today demonstrates we have a fabulous set of products overseen by a passionate and dedicated team, delivering robust financial numbers.”

Improbable also unveiled during the event its new positioning: Venture into new worlds and used this to provide a series of updates covering a range of subjects, starting with the market. This was followed by a presentation on the transformation of the Improbable organization; the AI and metaverse technology underpinning the business; the roadmap ahead for its ventures and partnerships arm and finally a financial performance update.

Financially, the business enjoyed revenue growth of 2.6x in 2022 increasing the top line to £78m. The business is getting ever closer to profitability with a £131m reduction of losses in 2022 to £19m.

Dan Odell, the Chief Financial Officer, says “The Improbable business has matured significantly in the past two years and these numbers are testament to that. The focus is now on industrializing what we are doing by being involved in more events with more people where there is scope to drive and monetize engagement levels.”

The business finished 2022 with cash of £140m signposting the support it has from its shareholders and its improved financial profile.

Peter Lipka, Chief Operating Officer, says, “Improbable emerged from 2022 a much stronger, leaner and more resilient entity. We should all be excited for the future as we have a fantastic foundation to build upon and deliver content at scale. Our venture building activity will see us initiate, grow and eventually spin-off a whole new set of businesses exploring the metaverse.”

The core business comprises three distinct activities: metaverse technology development, metaverse worlds and experiences building, and metaverse venture building. Improbable Labs is where creative innovation in product development lies. Ventures and partnerships include work done for large brands such as the recent agreement with Major League Baseball but also more experimental projects such as the Victory League, a soccer fan engagement project. Finally, there are initiatives Improbable seeks to launch or engage in as thought leaders in this space, such as its role as the founding group behind the launch of The Metaverse Society.

Rob Whitehead, Chief Product Officer, highlighted the progress made by the business in terms of its own proprietary innovations. His presentation showcased the order of magnitude improvements to existing games technology, at every level and how Improbable is solving the challenges of networking, rendering, simulation, voice and streaming at scale while embedding new generative AI capabilities.

Further updates about Improbable activities:

  • The Multiplayer Group (MPG) is currently working across more than 20 significant projects. Many of these games titles are coming to market this year, such as Starfield by Bethesda Game Studios. It launched on 6 September 2023 and surpassed 10 million players within two weeks, making it the biggest ever Bethesda game launch. Other new game releases in 2023 that have been supported by MPG include Mortal Kombat 1 by Netherealms/Warner Bros, Redfall by Arkane Austin/Bethesda Softworks, Lego 2K Drive by Visual Concepts/2K games, Firewall Ultra by First Contact Entertainment/Sony Interactive Entertainment.
  • Enterprise Insights, launched in 2023, develops accurate digital twins to assess the performance of infrastructure projects. The team is currently focused on supply chains, including the assessment of automated warehouses for a range of multinational companies.
  • Following our transformation, the Improbable business currently employs around 650 people.

Improbable is a British start-up that has been at the forefront of building virtual worlds for over a decade.

We believe that the metaverse is an opportunity for communities, companies and brands to have a positive social and economic impact in the real world. Today, we are initiating new technologies, models and partnerships to venture further into new worlds.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230926212157/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release

AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on

Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release

Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re

Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release

– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress

TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release

Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release

Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye